 Sean O'Leary
Concepts (568)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 121 | 2025 | 1398 | 19.610 |
Why?
| | Vaccines | 38 | 2024 | 411 | 10.600 |
Why?
| | Papillomavirus Vaccines | 36 | 2025 | 243 | 9.040 |
Why?
| | Influenza Vaccines | 43 | 2025 | 551 | 7.930 |
Why?
| | Immunization | 29 | 2025 | 414 | 6.110 |
Why?
| | Health Knowledge, Attitudes, Practice | 41 | 2025 | 1332 | 5.800 |
Why?
| | Parents | 39 | 2025 | 1363 | 5.360 |
Why?
| | Papillomavirus Infections | 22 | 2025 | 331 | 5.200 |
Why?
| | Influenza, Human | 26 | 2025 | 632 | 4.880 |
Why?
| | Immunization Programs | 15 | 2025 | 219 | 4.840 |
Why?
| | Motivational Interviewing | 12 | 2025 | 104 | 4.830 |
Why?
| | Vaccination Refusal | 14 | 2022 | 70 | 4.560 |
Why?
| | Obstetrics | 14 | 2022 | 166 | 4.440 |
Why?
| | Gynecology | 13 | 2022 | 178 | 4.090 |
Why?
| | Patient Acceptance of Health Care | 26 | 2025 | 809 | 3.780 |
Why?
| | Attitude of Health Personnel | 30 | 2025 | 1169 | 3.610 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1312 | 3.510 |
Why?
| | Advisory Committees | 20 | 2025 | 220 | 3.340 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 92 | 3.240 |
Why?
| | Immunization Schedule | 22 | 2025 | 200 | 3.210 |
Why?
| | Meningococcal Vaccines | 13 | 2025 | 57 | 2.990 |
Why?
| | Vaccination Coverage | 10 | 2025 | 84 | 2.870 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2023 | 389 | 2.790 |
Why?
| | Clergy | 4 | 2020 | 11 | 2.580 |
Why?
| | Physicians, Primary Care | 12 | 2024 | 236 | 2.470 |
Why?
| | Humans | 243 | 2025 | 137514 | 2.430 |
Why?
| | Child | 86 | 2025 | 22037 | 2.420 |
Why?
| | Colorado | 41 | 2025 | 4521 | 2.370 |
Why?
| | Health Personnel | 14 | 2024 | 699 | 2.340 |
Why?
| | Communication | 15 | 2025 | 874 | 2.260 |
Why?
| | Respiratory Syncytial Virus Vaccines | 8 | 2025 | 36 | 2.170 |
Why?
| | Hepatitis B | 4 | 2023 | 71 | 2.140 |
Why?
| | Female | 148 | 2025 | 73162 | 1.940 |
Why?
| | Pediatrics | 16 | 2021 | 1123 | 1.920 |
Why?
| | Health Communication | 4 | 2021 | 43 | 1.900 |
Why?
| | Viral Vaccines | 4 | 2024 | 98 | 1.890 |
Why?
| | Religion | 3 | 2020 | 69 | 1.880 |
Why?
| | Infant | 52 | 2025 | 9467 | 1.880 |
Why?
| | Pediatricians | 9 | 2024 | 131 | 1.870 |
Why?
| | Pregnancy | 46 | 2025 | 6745 | 1.840 |
Why?
| | Whooping Cough | 6 | 2022 | 51 | 1.770 |
Why?
| | Caregivers | 4 | 2025 | 872 | 1.760 |
Why?
| | Narration | 2 | 2025 | 58 | 1.750 |
Why?
| | United States | 59 | 2025 | 14696 | 1.730 |
Why?
| | Attitude to Health | 9 | 2020 | 444 | 1.710 |
Why?
| | Adult | 85 | 2025 | 37821 | 1.660 |
Why?
| | Adolescent | 66 | 2025 | 21555 | 1.610 |
Why?
| | Neurosurgical Procedures | 4 | 2025 | 199 | 1.430 |
Why?
| | Male | 102 | 2025 | 67718 | 1.370 |
Why?
| | Social Media | 4 | 2021 | 157 | 1.320 |
Why?
| | Treatment Refusal | 5 | 2020 | 89 | 1.310 |
Why?
| | Primary Health Care | 14 | 2024 | 1756 | 1.270 |
Why?
| | Child, Preschool | 35 | 2025 | 11097 | 1.200 |
Why?
| | Health Promotion | 5 | 2020 | 744 | 1.190 |
Why?
| | Mass Screening | 3 | 2025 | 1264 | 1.160 |
Why?
| | Surveys and Questionnaires | 33 | 2024 | 5772 | 1.150 |
Why?
| | Physicians, Family | 10 | 2021 | 206 | 1.150 |
Why?
| | Adolescent Health Services | 4 | 2015 | 75 | 1.140 |
Why?
| | Pseudotumor Cerebri | 2 | 2025 | 28 | 1.140 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2024 | 143 | 1.130 |
Why?
| | Qualitative Research | 12 | 2025 | 1361 | 1.060 |
Why?
| | Safety-net Providers | 3 | 2025 | 117 | 1.040 |
Why?
| | Measles | 4 | 2022 | 46 | 1.020 |
Why?
| | Prenatal Care | 2 | 2020 | 288 | 1.010 |
Why?
| | Middle Aged | 52 | 2025 | 33355 | 1.000 |
Why?
| | Spinal Cord | 2 | 2025 | 369 | 0.980 |
Why?
| | Practice Guidelines as Topic | 12 | 2025 | 1580 | 0.980 |
Why?
| | Physicians | 11 | 2022 | 904 | 0.970 |
Why?
| | Diphtheria | 4 | 2022 | 20 | 0.960 |
Why?
| | Measles-Mumps-Rubella Vaccine | 3 | 2022 | 41 | 0.960 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2023 | 182 | 0.960 |
Why?
| | Tetanus | 4 | 2022 | 25 | 0.960 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2025 | 25 | 0.960 |
Why?
| | Rural Health Services | 2 | 2024 | 128 | 0.950 |
Why?
| | Patient Outcome Assessment | 2 | 2019 | 132 | 0.950 |
Why?
| | Knee Prosthesis | 1 | 2025 | 21 | 0.950 |
Why?
| | Stereotaxic Techniques | 1 | 2025 | 40 | 0.940 |
Why?
| | Emergency Service, Hospital | 3 | 2025 | 2054 | 0.940 |
Why?
| | Bone Cysts, Aneurysmal | 1 | 2024 | 2 | 0.910 |
Why?
| | Health Care Surveys | 12 | 2021 | 567 | 0.910 |
Why?
| | Policy | 3 | 2020 | 150 | 0.910 |
Why?
| | Prosthesis Failure | 1 | 2025 | 116 | 0.900 |
Why?
| | Pandemics | 6 | 2024 | 1619 | 0.890 |
Why?
| | Orbital Diseases | 1 | 2024 | 32 | 0.880 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2024 | 58 | 0.870 |
Why?
| | Anterior Cruciate Ligament Injuries | 5 | 2024 | 159 | 0.860 |
Why?
| | Osteomyelitis | 2 | 2024 | 137 | 0.840 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2025 | 326 | 0.840 |
Why?
| | Trust | 4 | 2024 | 123 | 0.840 |
Why?
| | Laser Therapy | 1 | 2025 | 134 | 0.820 |
Why?
| | Ambulatory Care | 4 | 2020 | 539 | 0.810 |
Why?
| | Central Nervous System Neoplasms | 1 | 2025 | 158 | 0.800 |
Why?
| | Schools | 3 | 2025 | 465 | 0.790 |
Why?
| | Physician-Patient Relations | 5 | 2020 | 552 | 0.790 |
Why?
| | Religion and Medicine | 2 | 2019 | 27 | 0.790 |
Why?
| | Respiratory Syncytial Virus Infections | 5 | 2025 | 128 | 0.790 |
Why?
| | Health Equity | 1 | 2024 | 99 | 0.780 |
Why?
| | Developing Countries | 1 | 2024 | 305 | 0.780 |
Why?
| | Reminder Systems | 4 | 2019 | 176 | 0.780 |
Why?
| | Hepatitis B Vaccines | 4 | 2023 | 47 | 0.740 |
Why?
| | Young Adult | 27 | 2025 | 13243 | 0.740 |
Why?
| | Rural Population | 6 | 2024 | 567 | 0.740 |
Why?
| | Health Services Research | 4 | 2019 | 403 | 0.730 |
Why?
| | Refusal to Treat | 2 | 2020 | 17 | 0.730 |
Why?
| | Brain Neoplasms | 3 | 2025 | 1241 | 0.730 |
Why?
| | Urban Population | 4 | 2024 | 475 | 0.720 |
Why?
| | Global Health | 1 | 2024 | 386 | 0.720 |
Why?
| | Infant, Newborn | 16 | 2025 | 6059 | 0.710 |
Why?
| | Herpes Zoster Vaccine | 6 | 2022 | 162 | 0.710 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 65 | 0.710 |
Why?
| | Cochlear Implantation | 1 | 2022 | 93 | 0.700 |
Why?
| | Private Practice | 1 | 2020 | 24 | 0.690 |
Why?
| | Cochlear Implants | 1 | 2022 | 110 | 0.690 |
Why?
| | Standing Orders | 2 | 2020 | 11 | 0.690 |
Why?
| | Professional-Patient Relations | 3 | 2018 | 145 | 0.690 |
Why?
| | Pneumococcal Vaccines | 6 | 2021 | 145 | 0.690 |
Why?
| | Preventive Health Services | 2 | 2020 | 149 | 0.680 |
Why?
| | Registries | 5 | 2025 | 2021 | 0.670 |
Why?
| | Myocarditis | 1 | 2021 | 101 | 0.660 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 4 | 0.660 |
Why?
| | Health Care Costs | 3 | 2020 | 387 | 0.650 |
Why?
| | Stakeholder Participation | 1 | 2020 | 77 | 0.650 |
Why?
| | Longevity | 1 | 2021 | 165 | 0.650 |
Why?
| | Text Messaging | 3 | 2019 | 157 | 0.650 |
Why?
| | Freedom | 1 | 2019 | 14 | 0.640 |
Why?
| | Cross-Sectional Studies | 12 | 2024 | 5427 | 0.640 |
Why?
| | Community Participation | 1 | 2020 | 131 | 0.640 |
Why?
| | Brain Injuries, Traumatic | 1 | 2024 | 358 | 0.620 |
Why?
| | Hearing Loss | 1 | 2022 | 223 | 0.620 |
Why?
| | Healthcare Disparities | 3 | 2024 | 651 | 0.610 |
Why?
| | Public Health | 4 | 2024 | 579 | 0.610 |
Why?
| | Chickenpox Vaccine | 3 | 2017 | 73 | 0.610 |
Why?
| | Disease Outbreaks | 3 | 2022 | 376 | 0.600 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 152 | 0.590 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 33 | 0.580 |
Why?
| | Rotavirus Infections | 2 | 2021 | 45 | 0.570 |
Why?
| | Down Syndrome | 2 | 2021 | 492 | 0.570 |
Why?
| | Rotavirus Vaccines | 2 | 2021 | 49 | 0.570 |
Why?
| | Suicide | 1 | 2025 | 646 | 0.560 |
Why?
| | Documentation | 2 | 2019 | 189 | 0.560 |
Why?
| | Mothers | 5 | 2022 | 752 | 0.560 |
Why?
| | Patient Preference | 2 | 2017 | 190 | 0.560 |
Why?
| | Hepatitis A Vaccines | 4 | 2019 | 15 | 0.550 |
Why?
| | Infertility | 3 | 2023 | 55 | 0.540 |
Why?
| | Interviews as Topic | 6 | 2025 | 767 | 0.530 |
Why?
| | Retrospective Studies | 26 | 2025 | 15628 | 0.530 |
Why?
| | Cues | 1 | 2019 | 335 | 0.520 |
Why?
| | Mass Media | 1 | 2016 | 42 | 0.520 |
Why?
| | Physician's Role | 2 | 2019 | 206 | 0.520 |
Why?
| | Mumps | 3 | 2022 | 24 | 0.500 |
Why?
| | Health Education | 2 | 2018 | 343 | 0.500 |
Why?
| | Evidence-Based Medicine | 5 | 2024 | 746 | 0.500 |
Why?
| | Health Policy | 2 | 2025 | 388 | 0.480 |
Why?
| | Delivery of Health Care | 3 | 2023 | 948 | 0.480 |
Why?
| | Cost-Benefit Analysis | 4 | 2024 | 593 | 0.480 |
Why?
| | School Health Services | 3 | 2015 | 243 | 0.480 |
Why?
| | Vaccines, Combined | 4 | 2023 | 48 | 0.480 |
Why?
| | Computers, Handheld | 1 | 2015 | 25 | 0.470 |
Why?
| | Neuroendoscopy | 2 | 2025 | 23 | 0.470 |
Why?
| | Aged | 25 | 2025 | 23798 | 0.460 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2018 | 255 | 0.460 |
Why?
| | Dengue Vaccines | 3 | 2019 | 10 | 0.450 |
Why?
| | Anthrax Vaccines | 3 | 2018 | 7 | 0.450 |
Why?
| | Streptococcal Vaccines | 1 | 2014 | 6 | 0.440 |
Why?
| | Hepatitis B Surface Antigens | 2 | 2023 | 24 | 0.420 |
Why?
| | Recovery of Function | 2 | 2020 | 662 | 0.420 |
Why?
| | Aged, 80 and over | 10 | 2025 | 7593 | 0.410 |
Why?
| | United Kingdom | 6 | 2025 | 324 | 0.410 |
Why?
| | Internet | 5 | 2019 | 656 | 0.410 |
Why?
| | Seizures, Febrile | 1 | 2012 | 21 | 0.390 |
Why?
| | Patient-Centered Care | 2 | 2015 | 527 | 0.390 |
Why?
| | Washington | 2 | 2025 | 154 | 0.390 |
Why?
| | Meningococcal Infections | 3 | 2018 | 25 | 0.390 |
Why?
| | Treatment Outcome | 11 | 2025 | 10821 | 0.380 |
Why?
| | Anti-Bacterial Agents | 5 | 2024 | 1800 | 0.380 |
Why?
| | Safety | 2 | 2020 | 342 | 0.380 |
Why?
| | Nurseries, Hospital | 1 | 2012 | 5 | 0.380 |
Why?
| | Herpes Zoster | 3 | 2022 | 318 | 0.380 |
Why?
| | Infertility, Female | 3 | 2021 | 108 | 0.380 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 15 | 0.380 |
Why?
| | Georgia | 6 | 2021 | 84 | 0.370 |
Why?
| | Streptococcal Infections | 1 | 2014 | 151 | 0.370 |
Why?
| | Anti-Mullerian Hormone | 2 | 2022 | 57 | 0.370 |
Why?
| | Age Factors | 6 | 2021 | 3301 | 0.360 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 161 | 0.360 |
Why?
| | Family Practice | 7 | 2017 | 467 | 0.350 |
Why?
| | Skin Diseases, Bacterial | 3 | 2016 | 21 | 0.350 |
Why?
| | Rotator Cuff | 3 | 2009 | 47 | 0.350 |
Why?
| | Mumps Vaccine | 3 | 2021 | 13 | 0.340 |
Why?
| | Pertussis Vaccine | 3 | 2022 | 23 | 0.340 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2022 | 1465 | 0.330 |
Why?
| | Tenodesis | 1 | 2009 | 20 | 0.320 |
Why?
| | Attitude | 3 | 2021 | 262 | 0.320 |
Why?
| | Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.310 |
Why?
| | Australia | 4 | 2023 | 314 | 0.300 |
Why?
| | Vaccines, Contraceptive | 1 | 2008 | 1 | 0.300 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2249 | 0.300 |
Why?
| | Egg Proteins | 1 | 2008 | 17 | 0.300 |
Why?
| | Tendon Injuries | 1 | 2009 | 70 | 0.300 |
Why?
| | Ovulation | 1 | 2008 | 40 | 0.300 |
Why?
| | Hepatitis B virus | 2 | 2023 | 40 | 0.300 |
Why?
| | Guideline Adherence | 2 | 2013 | 549 | 0.290 |
Why?
| | Ovarian Follicle | 1 | 2008 | 71 | 0.290 |
Why?
| | Cytomegalovirus | 1 | 2008 | 160 | 0.270 |
Why?
| | Professional-Family Relations | 3 | 2018 | 141 | 0.270 |
Why?
| | Societies, Medical | 4 | 2019 | 820 | 0.270 |
Why?
| | Child Health | 2 | 2019 | 157 | 0.270 |
Why?
| | Maternal Health Services | 2 | 2019 | 97 | 0.270 |
Why?
| | Vaccines, Synthetic | 3 | 2022 | 126 | 0.260 |
Why?
| | Mobile Applications | 2 | 2020 | 180 | 0.260 |
Why?
| | Propensity Score | 2 | 2025 | 288 | 0.260 |
Why?
| | Respiratory Syncytial Viruses | 2 | 2023 | 52 | 0.260 |
Why?
| | Databases, Factual | 4 | 2025 | 1351 | 0.260 |
Why?
| | Logistic Models | 3 | 2021 | 2064 | 0.250 |
Why?
| | Receptors, Cell Surface | 1 | 2008 | 391 | 0.250 |
Why?
| | Data Collection | 3 | 2014 | 674 | 0.250 |
Why?
| | Postoperative Complications | 3 | 2025 | 2641 | 0.250 |
Why?
| | Arthroplasty | 2 | 2003 | 48 | 0.240 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 501 | 0.240 |
Why?
| | Polyethylene | 1 | 2025 | 14 | 0.240 |
Why?
| | Acetazolamide | 1 | 2025 | 26 | 0.240 |
Why?
| | Child Care | 1 | 2025 | 31 | 0.240 |
Why?
| | Pneumocephalus | 1 | 2025 | 4 | 0.240 |
Why?
| | Arachnoid Cysts | 1 | 2025 | 7 | 0.240 |
Why?
| | Skull Base | 1 | 2025 | 53 | 0.240 |
Why?
| | Shoulder Joint | 2 | 2008 | 171 | 0.240 |
Why?
| | Cerebrospinal Fluid Rhinorrhea | 1 | 2024 | 10 | 0.230 |
Why?
| | Privacy | 1 | 2025 | 42 | 0.230 |
Why?
| | Cerebral Ventricles | 1 | 2025 | 52 | 0.230 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2025 | 50 | 0.230 |
Why?
| | Haemophilus Vaccines | 1 | 2024 | 30 | 0.230 |
Why?
| | Intracranial Hemorrhages | 1 | 2025 | 84 | 0.230 |
Why?
| | Syndrome | 1 | 2025 | 359 | 0.220 |
Why?
| | Community Health Centers | 1 | 2024 | 59 | 0.220 |
Why?
| | Time Factors | 4 | 2020 | 6817 | 0.220 |
Why?
| | Pregnancy Rate | 5 | 2023 | 65 | 0.220 |
Why?
| | California | 3 | 2025 | 425 | 0.220 |
Why?
| | Astrocytoma | 1 | 2025 | 128 | 0.220 |
Why?
| | Cohort Studies | 5 | 2025 | 5730 | 0.220 |
Why?
| | Acne Vulgaris | 1 | 2024 | 28 | 0.220 |
Why?
| | Prosthesis Design | 2 | 2025 | 309 | 0.220 |
Why?
| | Patellar Ligament | 1 | 2024 | 25 | 0.220 |
Why?
| | Absenteeism | 1 | 2024 | 49 | 0.220 |
Why?
| | Home Health Aides | 1 | 2023 | 6 | 0.220 |
Why?
| | Tibia | 1 | 2025 | 177 | 0.210 |
Why?
| | Seasons | 2 | 2020 | 546 | 0.210 |
Why?
| | Patient Education as Topic | 2 | 2019 | 766 | 0.210 |
Why?
| | Musculoskeletal Diseases | 1 | 2025 | 77 | 0.210 |
Why?
| | Orbit | 1 | 2024 | 70 | 0.210 |
Why?
| | Bacterial Vaccines | 1 | 2024 | 63 | 0.210 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2024 | 86 | 0.210 |
Why?
| | Blood Coagulation Tests | 1 | 2023 | 67 | 0.210 |
Why?
| | Reoperation | 2 | 2025 | 569 | 0.210 |
Why?
| | Decision Making | 3 | 2020 | 906 | 0.200 |
Why?
| | Pituitary Neoplasms | 1 | 2025 | 190 | 0.200 |
Why?
| | Drug Resistant Epilepsy | 1 | 2024 | 102 | 0.200 |
Why?
| | Audiometry, Evoked Response | 1 | 2022 | 12 | 0.200 |
Why?
| | Silicone Elastomers | 1 | 2002 | 7 | 0.200 |
Why?
| | Oxytocics | 1 | 2022 | 15 | 0.200 |
Why?
| | Hospitalization | 8 | 2024 | 2197 | 0.200 |
Why?
| | Gout | 1 | 2003 | 36 | 0.200 |
Why?
| | Joint Prosthesis | 1 | 2002 | 20 | 0.200 |
Why?
| | Biological Transport | 1 | 2024 | 416 | 0.200 |
Why?
| | Blood Transfusion | 1 | 2025 | 324 | 0.200 |
Why?
| | Hospitals | 3 | 2023 | 678 | 0.200 |
Why?
| | Prostaglandins | 1 | 2022 | 97 | 0.200 |
Why?
| | Thumb | 1 | 2002 | 26 | 0.200 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 807 | 0.190 |
Why?
| | Ovulation Induction | 2 | 2022 | 56 | 0.190 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2022 | 8 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2025 | 339 | 0.190 |
Why?
| | Algorithms | 3 | 2025 | 1702 | 0.190 |
Why?
| | Prospective Studies | 4 | 2022 | 7598 | 0.190 |
Why?
| | Rubella | 1 | 2022 | 24 | 0.190 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2023 | 147 | 0.190 |
Why?
| | Radiosurgery | 1 | 2025 | 346 | 0.190 |
Why?
| | Infant Health | 1 | 2022 | 25 | 0.190 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 16 | 0.190 |
Why?
| | Orthopedic Procedures | 2 | 2023 | 222 | 0.190 |
Why?
| | Uterine Diseases | 1 | 2021 | 16 | 0.180 |
Why?
| | Cochlea | 1 | 2022 | 102 | 0.180 |
Why?
| | Fertilization in Vitro | 4 | 2023 | 83 | 0.180 |
Why?
| | Intention | 2 | 2020 | 171 | 0.180 |
Why?
| | Russia | 1 | 2021 | 11 | 0.180 |
Why?
| | Intrauterine Devices | 1 | 2021 | 30 | 0.180 |
Why?
| | Live Birth | 4 | 2023 | 65 | 0.180 |
Why?
| | Knee Injuries | 1 | 2022 | 100 | 0.180 |
Why?
| | Automobile Driving | 1 | 2023 | 147 | 0.180 |
Why?
| | Yellow Fever Vaccine | 2 | 2017 | 6 | 0.180 |
Why?
| | Germany | 1 | 2021 | 121 | 0.180 |
Why?
| | Risk | 2 | 2015 | 905 | 0.180 |
Why?
| | Hospital Rapid Response Team | 1 | 2021 | 17 | 0.180 |
Why?
| | Regression Analysis | 2 | 2020 | 1029 | 0.170 |
Why?
| | Demography | 2 | 2024 | 292 | 0.170 |
Why?
| | Complementary Therapies | 1 | 2022 | 93 | 0.170 |
Why?
| | General Practitioners | 1 | 2021 | 28 | 0.170 |
Why?
| | Disease Management | 1 | 2025 | 625 | 0.170 |
Why?
| | Cluster Analysis | 2 | 2022 | 502 | 0.170 |
Why?
| | Triage | 1 | 2023 | 221 | 0.170 |
Why?
| | Internal Medicine | 2 | 2014 | 254 | 0.170 |
Why?
| | Age Distribution | 1 | 2021 | 391 | 0.170 |
Why?
| | Antiviral Agents | 2 | 2023 | 740 | 0.170 |
Why?
| | Clinical Competence | 2 | 2018 | 1093 | 0.170 |
Why?
| | Osteoarthritis | 1 | 2002 | 185 | 0.170 |
Why?
| | Anterior Cruciate Ligament | 2 | 2024 | 81 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2024 | 346 | 0.160 |
Why?
| | Thrombosis | 1 | 2024 | 368 | 0.160 |
Why?
| | Staphylococcal Infections | 1 | 2025 | 402 | 0.160 |
Why?
| | Measles Vaccine | 1 | 2019 | 21 | 0.160 |
Why?
| | Drug Storage | 1 | 2020 | 58 | 0.160 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.160 |
Why?
| | Fever | 1 | 2021 | 307 | 0.160 |
Why?
| | Eligibility Determination | 1 | 2020 | 66 | 0.160 |
Why?
| | Suicidal Ideation | 1 | 2025 | 523 | 0.160 |
Why?
| | Pennsylvania | 1 | 2019 | 116 | 0.160 |
Why?
| | State Government | 1 | 2019 | 42 | 0.160 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2020 | 94 | 0.160 |
Why?
| | Reimbursement Mechanisms | 1 | 2020 | 84 | 0.160 |
Why?
| | Government Regulation | 1 | 2019 | 55 | 0.160 |
Why?
| | Medicaid | 2 | 2021 | 436 | 0.160 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2017 | 100 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 68 | 0.150 |
Why?
| | Motivation | 1 | 2024 | 571 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2025 | 3546 | 0.150 |
Why?
| | Therapeutic Uses | 1 | 2018 | 1 | 0.150 |
Why?
| | Europe | 1 | 2020 | 414 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 322 | 0.150 |
Why?
| | Insemination, Artificial | 1 | 2018 | 10 | 0.150 |
Why?
| | Clomiphene | 1 | 2018 | 15 | 0.150 |
Why?
| | Fertility Agents, Female | 1 | 2018 | 20 | 0.150 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 405 | 0.150 |
Why?
| | Risk Factors | 7 | 2024 | 10356 | 0.150 |
Why?
| | Urban Health Services | 1 | 2018 | 65 | 0.150 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 6 | 0.140 |
Why?
| | Education, Continuing | 1 | 2018 | 40 | 0.140 |
Why?
| | Melanoma | 1 | 2025 | 758 | 0.140 |
Why?
| | Nuclear Family | 1 | 2018 | 54 | 0.140 |
Why?
| | Placentation | 1 | 2017 | 45 | 0.140 |
Why?
| | Ambulatory Care Facilities | 2 | 2019 | 233 | 0.140 |
Why?
| | Evidence-Based Practice | 2 | 2020 | 223 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2025 | 853 | 0.140 |
Why?
| | Guatemala | 4 | 2020 | 333 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1639 | 0.140 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2018 | 68 | 0.140 |
Why?
| | Quality Improvement | 3 | 2020 | 1161 | 0.140 |
Why?
| | Cervical Plexus | 1 | 1997 | 1 | 0.140 |
Why?
| | Trace Elements | 1 | 2017 | 52 | 0.130 |
Why?
| | Spinal Nerve Roots | 1 | 1997 | 25 | 0.130 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2017 | 78 | 0.130 |
Why?
| | Altitude | 1 | 2021 | 482 | 0.130 |
Why?
| | Morphogenesis | 1 | 2017 | 166 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1524 | 0.130 |
Why?
| | Administrative Personnel | 1 | 2016 | 30 | 0.130 |
Why?
| | Travel | 1 | 2017 | 130 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2018 | 116 | 0.130 |
Why?
| | Hemorrhage | 1 | 2021 | 723 | 0.130 |
Why?
| | Allied Health Personnel | 1 | 2016 | 46 | 0.130 |
Why?
| | Physician Executives | 1 | 2016 | 32 | 0.130 |
Why?
| | Cost of Illness | 2 | 2018 | 304 | 0.130 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 65 | 0.130 |
Why?
| | Adaptation, Psychological | 2 | 2020 | 653 | 0.130 |
Why?
| | Behavior Therapy | 1 | 2019 | 262 | 0.130 |
Why?
| | Public Health Practice | 1 | 2016 | 66 | 0.120 |
Why?
| | Diphtheria Toxoid | 1 | 2015 | 12 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 980 | 0.120 |
Why?
| | Tetanus Toxoid | 1 | 2015 | 37 | 0.120 |
Why?
| | Health Services Accessibility | 2 | 2024 | 976 | 0.120 |
Why?
| | Herpesvirus 3, Human | 1 | 2019 | 334 | 0.120 |
Why?
| | Incidence | 2 | 2020 | 2792 | 0.120 |
Why?
| | Minority Groups | 1 | 2018 | 269 | 0.120 |
Why?
| | Patient Participation | 1 | 2019 | 423 | 0.120 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 75 | 0.120 |
Why?
| | Equipment and Supplies | 1 | 2015 | 41 | 0.120 |
Why?
| | Focus Groups | 5 | 2018 | 512 | 0.120 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2018 | 176 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 341 | 0.120 |
Why?
| | Information Dissemination | 1 | 2017 | 218 | 0.120 |
Why?
| | Cooperative Behavior | 3 | 2014 | 447 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2017 | 162 | 0.120 |
Why?
| | Leadership | 1 | 2019 | 382 | 0.120 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2017 | 213 | 0.120 |
Why?
| | Africa | 2 | 2025 | 109 | 0.120 |
Why?
| | Neck Pain | 1 | 2014 | 27 | 0.110 |
Why?
| | Occupational Health Services | 1 | 2014 | 31 | 0.110 |
Why?
| | Lung Diseases | 1 | 2021 | 768 | 0.110 |
Why?
| | Acute Disease | 4 | 2025 | 1008 | 0.110 |
Why?
| | Zinc | 1 | 2017 | 298 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2719 | 0.110 |
Why?
| | Poverty | 1 | 2018 | 520 | 0.110 |
Why?
| | Nurses | 1 | 2016 | 174 | 0.110 |
Why?
| | State Medicine | 2 | 2024 | 24 | 0.110 |
Why?
| | Public Health Administration | 1 | 2014 | 75 | 0.110 |
Why?
| | Sexual Behavior | 1 | 2018 | 487 | 0.100 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.100 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 321 | 0.100 |
Why?
| | Intussusception | 1 | 2013 | 29 | 0.100 |
Why?
| | Social Behavior | 1 | 2015 | 300 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 52 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 536 | 0.100 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 64 | 0.100 |
Why?
| | Hemodynamics | 1 | 2017 | 1114 | 0.100 |
Why?
| | Fertilization | 2 | 2023 | 44 | 0.100 |
Why?
| | Workplace | 1 | 2014 | 261 | 0.100 |
Why?
| | Parent-Child Relations | 1 | 2015 | 272 | 0.100 |
Why?
| | Brain | 1 | 2024 | 2831 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5139 | 0.090 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 23 | 0.090 |
Why?
| | Professional Practice Location | 1 | 2011 | 30 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 586 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 99 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1040 | 0.090 |
Why?
| | Outpatients | 1 | 2015 | 393 | 0.090 |
Why?
| | Perinatal Care | 1 | 2012 | 56 | 0.090 |
Why?
| | Placenta | 1 | 2017 | 754 | 0.090 |
Why?
| | Sensitivity and Specificity | 3 | 2025 | 1950 | 0.090 |
Why?
| | Birth Rate | 2 | 2022 | 30 | 0.090 |
Why?
| | Quality of Life | 3 | 2024 | 2870 | 0.080 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 48 | 0.080 |
Why?
| | Swine | 1 | 2013 | 775 | 0.080 |
Why?
| | Hospices | 1 | 2011 | 87 | 0.080 |
Why?
| | Pain Measurement | 1 | 2012 | 552 | 0.080 |
Why?
| | Cognition | 1 | 2018 | 1192 | 0.080 |
Why?
| | Sports | 1 | 2012 | 229 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2521 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2011 | 124 | 0.080 |
Why?
| | Rotator Cuff Injuries | 1 | 2009 | 60 | 0.080 |
Why?
| | Activities of Daily Living | 1 | 2012 | 414 | 0.080 |
Why?
| | Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.080 |
Why?
| | Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.080 |
Why?
| | Communicable Diseases | 2 | 2022 | 160 | 0.080 |
Why?
| | Connexin 43 | 1 | 2008 | 33 | 0.070 |
Why?
| | Embryonic Development | 1 | 2008 | 118 | 0.070 |
Why?
| | Appointments and Schedules | 2 | 2019 | 89 | 0.070 |
Why?
| | Cell Phone | 2 | 2019 | 75 | 0.070 |
Why?
| | Tendons | 1 | 2008 | 111 | 0.070 |
Why?
| | Leukocytes | 1 | 2008 | 311 | 0.070 |
Why?
| | Ovary | 1 | 2008 | 218 | 0.060 |
Why?
| | Health Surveys | 2 | 2018 | 520 | 0.060 |
Why?
| | Mice, Inbred BALB C | 1 | 2008 | 1271 | 0.060 |
Why?
| | Sphenoid Sinus | 1 | 2025 | 11 | 0.060 |
Why?
| | Sphenoid Bone | 1 | 2025 | 17 | 0.060 |
Why?
| | Central Nervous System Cysts | 1 | 2025 | 14 | 0.060 |
Why?
| | Fetal Development | 1 | 2008 | 296 | 0.060 |
Why?
| | Immobilization | 1 | 2004 | 44 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2008 | 504 | 0.060 |
Why?
| | Tetracyclines | 1 | 2024 | 11 | 0.060 |
Why?
| | Animals | 4 | 2024 | 37011 | 0.060 |
Why?
| | Technology Assessment, Biomedical | 1 | 2024 | 34 | 0.060 |
Why?
| | Smallpox Vaccine | 1 | 2024 | 23 | 0.050 |
Why?
| | Electrodes, Implanted | 1 | 2024 | 116 | 0.050 |
Why?
| | Shoulder Dislocation | 1 | 2004 | 50 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2024 | 112 | 0.050 |
Why?
| | Ligaments | 1 | 2024 | 60 | 0.050 |
Why?
| | Palivizumab | 1 | 2023 | 13 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 233 | 0.050 |
Why?
| | Acromion | 1 | 2003 | 8 | 0.050 |
Why?
| | National Health Programs | 1 | 2023 | 21 | 0.050 |
Why?
| | Prognosis | 2 | 2023 | 4031 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2666 | 0.050 |
Why?
| | Adenoma | 1 | 2025 | 230 | 0.050 |
Why?
| | Labor, Induced | 1 | 2022 | 32 | 0.050 |
Why?
| | Health Services | 1 | 2023 | 103 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 72 | 0.050 |
Why?
| | Technology | 1 | 2023 | 95 | 0.050 |
Why?
| | Term Birth | 1 | 2022 | 23 | 0.050 |
Why?
| | Joint Instability | 1 | 2024 | 170 | 0.050 |
Why?
| | Sheep | 1 | 2024 | 855 | 0.050 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2001 | 30 | 0.050 |
Why?
| | Hysteroscopy | 1 | 2021 | 12 | 0.050 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2025 | 236 | 0.050 |
Why?
| | Hand Strength | 1 | 2002 | 122 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 32 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 849 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2001 | 63 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2025 | 950 | 0.040 |
Why?
| | Psychiatric Nursing | 1 | 2001 | 10 | 0.040 |
Why?
| | Dissociative Disorders | 1 | 2001 | 22 | 0.040 |
Why?
| | Autonomic Nervous System | 1 | 2001 | 80 | 0.040 |
Why?
| | Multigene Family | 1 | 2001 | 202 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| | Cadaver | 2 | 2004 | 319 | 0.040 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 37 | 0.040 |
Why?
| | Nurse-Patient Relations | 1 | 2001 | 65 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 131 | 0.040 |
Why?
| | Hip Prosthesis | 1 | 2000 | 40 | 0.040 |
Why?
| | Transcription Factors | 1 | 2008 | 1717 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2020 | 66 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2002 | 272 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2001 | 263 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 496 | 0.040 |
Why?
| | Social Networking | 1 | 2020 | 34 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 502 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2021 | 223 | 0.040 |
Why?
| | Lower Extremity | 1 | 2023 | 427 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 130 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 750 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 308 | 0.040 |
Why?
| | Nursing Staff, Hospital | 1 | 2001 | 154 | 0.040 |
Why?
| | Knee Joint | 1 | 2022 | 405 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 44 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 260 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 895 | 0.040 |
Why?
| | Family | 1 | 2022 | 667 | 0.040 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 75 | 0.040 |
Why?
| | Crohn Disease | 1 | 2001 | 242 | 0.040 |
Why?
| | Awareness | 1 | 2018 | 104 | 0.040 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 25 | 0.030 |
Why?
| | Heart Rate | 1 | 2001 | 831 | 0.030 |
Why?
| | Accessory Nerve | 1 | 1997 | 5 | 0.030 |
Why?
| | Internationality | 1 | 2018 | 155 | 0.030 |
Why?
| | Patients | 1 | 2018 | 175 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 483 | 0.030 |
Why?
| | Risk Assessment | 3 | 2015 | 3439 | 0.030 |
Why?
| | Health Plan Implementation | 1 | 2018 | 140 | 0.030 |
Why?
| | Mice | 2 | 2017 | 17843 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 207 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 228 | 0.030 |
Why?
| | Genetic Variation | 1 | 2001 | 986 | 0.030 |
Why?
| | Nurse Practitioners | 1 | 2018 | 135 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 413 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 831 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1324 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 576 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2019 | 657 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 353 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2025 | 2681 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1703 | 0.030 |
Why?
| | Ergonomics | 1 | 2014 | 25 | 0.030 |
Why?
| | Prescriptions | 1 | 2014 | 67 | 0.030 |
Why?
| | Wound Infection | 1 | 2014 | 33 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2018 | 419 | 0.030 |
Why?
| | Efficiency | 1 | 2014 | 98 | 0.030 |
Why?
| | Occupational Injuries | 1 | 2014 | 46 | 0.030 |
Why?
| | Abscess | 1 | 2014 | 76 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2183 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 892 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2857 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2074 | 0.030 |
Why?
| | Cytokines | 1 | 2001 | 2095 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2014 | 129 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 192 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2001 | 2420 | 0.020 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.020 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 84 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1273 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 768 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2014 | 780 | 0.020 |
Why?
| | Exercise | 2 | 2014 | 2024 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2838 | 0.020 |
Why?
| | Rotation | 1 | 2004 | 116 | 0.010 |
Why?
| | Palliative Care | 1 | 2011 | 738 | 0.010 |
Why?
| | Posture | 1 | 2004 | 185 | 0.010 |
Why?
| | Range of Motion, Articular | 1 | 2004 | 392 | 0.010 |
Why?
| | Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
| | Nursing Methodology Research | 1 | 2001 | 48 | 0.010 |
Why?
| | Helping Behavior | 1 | 2001 | 20 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 268 | 0.010 |
Why?
| | Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| | Durapatite | 1 | 2000 | 37 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 523 | 0.010 |
Why?
| | Psychological Theory | 1 | 2001 | 98 | 0.010 |
Why?
| | Bone Cements | 1 | 2000 | 42 | 0.010 |
Why?
| | Porosity | 1 | 2000 | 99 | 0.010 |
Why?
| | Coated Materials, Biocompatible | 1 | 2000 | 62 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1320 | 0.010 |
Why?
| | Social Support | 1 | 2001 | 616 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2001 | 2193 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2001 | 1115 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|